Detalles de la búsqueda
1.
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
BMC Infect Dis;
20(1): 543, 2020 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711457
2.
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
Clin Infect Dis;
62(4): 418-430, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26508515
3.
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Emerg Infect Dis;
21(6): 977-83, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25988299
4.
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
PLoS Med;
12(12): e1001932, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26714320
5.
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Lancet;
380(9851): 1406-17, 2012 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22938757
6.
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.
Lancet Infect Dis;
17(7): 707-715, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28499828
7.
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.
Lancet Respir Med;
3(3): 201-9, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25726085
Resultados
1 -
7
de 7
1
Próxima >
>>